Dr. Stephan Huddleston, MD
Claim this profileCharles Retina Institute
Studies Retinal Disease
Studies Diabetic Retinopathy
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Stephan Huddleston, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Stephan Huddleston, MD has experience with
- Aflibercept Injection
Breakdown of trials Stephan Huddleston, MD has run
Retinal Disease
Diabetic Retinopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Huddleston, MD specialize in?
Stephan Huddleston, MD focuses on Retinal Disease and Diabetic Retinopathy. In particular, much of their work with Retinal Disease has involved treating patients, or patients who are undergoing treatment.
Is Stephan Huddleston, MD currently recruiting for clinical trials?
No, Stephan Huddleston, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Stephan Huddleston, MD has studied deeply?
Yes, Stephan Huddleston, MD has studied treatments such as Aflibercept Injection.
What is the best way to schedule an appointment with Stephan Huddleston, MD?
Apply for one of the trials that Stephan Huddleston, MD is conducting.
What is the office address of Stephan Huddleston, MD?
The office of Stephan Huddleston, MD is located at: Charles Retina Institute, Germantown, Tennessee 38138 United States. This is the address for their practice at the Charles Retina Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.